Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. (2020)
Attributed to:
MICA: New combination therapy against MDR TB targeting the respiratory chain
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.05.01.20087130
PubMed Identifier: 32511548
Publication URI: http://europepmc.org/abstract/MED/32511548
Type: Journal Article/Review
Parent Publication: medRxiv : the preprint server for health sciences